Description: Life Reinsurance Data from the Munich American Survey by James L. Sweeney and David M. Bruggeman Reinsurance Section News, August 1998, Issue No. 44.

Description: This article presents the results from 1998 Munich American survey of Life Reinsurance production.

Description: With the medical insurance market experiencing health care inflation of 10 to 13 percent and medical costs averaging above $8,000 per year per employee less for single employees and more for employees with families, employers are looking at alternative options. Politicians and regulators are as well.

Description: Attitudes on strategy and risk in reinsurance vary according to specific environmental circumstances for most companies. This article is an extract from the 2007 surveys in the U.S. market.

Description: Feature article discussing one company’s guidelines for social media use.

Description: Historically low interest rates, historically high equity market volatility and ever increasing life spans have made pension funding a hot topic. Financing the lifestyles of the superannuated through steadily improving investment performance is no longer a given. Market realities and stricter regulatory funding requirements are forcing plan sponsors to reduce overly optimistic assumptions about how well their investments will perform and increase assumptions about how long they will have to last. A growing number of well-known corporations are looking for help in trying to make the math work. This article discusses the opportunities for all who want to take on longevity risk.

Description: This article summarizes the Reinsurance Section's recent research efforts.

Description: description of theme of the 2017 Canadian Reinsurance Conference

Description: The diary of Dirk Nieder, an actuary who traveled in Asia amid the COVID-19 pandemic, tying in what he saw in asia countries and developments from the west.

Description: As today's medical and technological advances continue to be utilized and applied to diabetes mellitus (DM), a newer and even more complex framework for the disease is emerging, which may help us further our understanding of it. This article explores the most recent classification update and some of the newer thinking emerging about DM.